Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Lymphoma Clinical Trials in Arizona | 389 Studies

Clinical Trials LymphomaArizona

Lymphoma Clinical Trials in Arizona

Find 389 clinical trials for lymphoma near Arizona. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Arizona

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 181-200 of 389 trials

Active not recruitingCombination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic LeukemiaThis randomized phase III trial studies combination chemotherapy with blinatumomab to see how well it works compared to induction chemotherapy alone in treating patients with…NCT02003222·Birmingham, Alabama and 543 others

PreviousPage 10 of 20Next

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedS0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy, such as cisplatin, etoposide, gemcitabine, and methylprednisolone, work in different ways to stop the growth of cancer cells, either by…NCT00109928·Tucson, Arizona and 76 others

RecruitingA Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular LymphomaThis study is researching an experimental drug called odronextamab, referred to as study drug.NCT06091254·Tucson, Arizona and 189 others

CompletedA Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199This is an open-label multicenter, study to assess the pharmacokinetic interaction of ketoconazole with ABT-199 in up to 12 subjects with relapsed or refractory non-Hodgkin's…NCT01969669·Tucson, Arizona and 2 others

Active not recruitingA Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)This study aims to evaluate the safety, tolerability, pharmacodynamic, and pharmacokinetic (PK) of nemtabrutinib (formerly ARQ 531) tablets in selected participants with relapsed…NCT03162536·Scottsdale, Arizona and 9 others

CompletedTREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's DiseaseThis study is designed to determine the effect of 2 gram/day of ethyl-EPA on motor (movement) signs and symptoms of Huntington disease.NCT00146211·Birmingham, Alabama and 40 others

CompletedMLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- VincristineThis is a single-arm, open-label, multicenter, dose escalation, phase 1-2 study of alisertib (MLN8237) administered in patients with relapsed or refractory diffuse large B-cell…NCT01397825·Tucson, Arizona and 24 others

CompletedSelumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH trial studies how well selumetinib sulfate works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with MAPK…NCT03213691·Birmingham, Alabama and 109 others

RecruitingA Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell MalignanciesThe purpose of this study is to measure the safety, preliminary antitumor activity, pharmacokinetics, and pharmacodynamics with tacabrutideg in combination with other agents in…NCT06634589·Phoenix, Arizona and 48 others

TerminatedPentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell TransplantationThis study tests the hypothesis that a purely immunosuppressive preparative regimen allows engraftment of related or unrelated allogeneic hematopoietic stem cells in subjects with…NCT00698685·Tucson, Arizona and 1 other

CompletedA Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell LymphomaThe purpose of this study is to evaluate the safety/tolerability and efficacy of itacitinib in combination with ibrutinib in subjects with relapsed or refractory diffuse large…NCT02760485·Scottsdale, Arizona and 20 others

CompletedTrial of AVN-944 in Patients With Advanced Hematologic MalignanciesThe purpose of this study is to determine the safety and maximum tolerated dose, pharmacokinetics, and anti-neoplastic response of AVN-944 in patients with advanced hematologic…NCT00273936·Tucson, Arizona and 4 others

CompletedPegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)This pilot clinical trial studies the side effects of pegaspargase when given together with combination chemotherapy in treating patients with newly diagnosed high-risk acute…NCT00866307·Phoenix, Arizona and 27 others

CompletedStudy Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin LymphomaThis study will be separated into 3 distinct phases designated as the Phase 1 study, Phase 2 pivotal study (Cohort 1 and Cohort 2), and Phase 2 safety management study (Cohort 3…NCT02348216·Gilbert, Arizona and 35 others

TerminatedStudy of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)The purpose of this study is to assess whether copanlisib in combination with standard immunochemotherapy (rituximab in combination with bendamustine \[R-B\] and rituximab in…NCT02626455·Chandler, Arizona and 200 others

CompletedPanobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaPanobinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.NCT01261247·Scottsdale, Arizona and 1 other

CompletedCombination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00005601·Scottsdale, Arizona and 20 others

CompletedLenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-cell NHL.NCT01996865·Tucson, Arizona and 125 others

CompletedDepsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell LymphomaBackground: NSC630176 is a depsipeptide fermentation product from Chromobacterium violaceum with potent cytotoxic activity against human tumor cell lines and in vivo efficacy…NCT00007345·Scottsdale, Arizona and 12 others

CompletedSafety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's LymphomaTo determine what side effects and what clinical effect, if any, the administration of this investigational product, IDEC-114 in combination with Rituxan® \[Rituxan® as a single…NCT00048555·Birmingham, Alabama and 21 others

Other Conditions in Arizona

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia